MedPath

许昌未来制药有限责任公司

Ownership
-
Established
1999-04-28
Employees
-
Market Cap
-
Website
www.bz100.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

133

NMPA:133

Drug Approvals

Vitamin B₆ Injection

Product Name
维生素B6注射液
Approval Number
国药准字H20258015
Approval Date
Feb 5, 2025
NMPA

Multi-Trace Elements Injection(II)

Product Name
多种微量元素注射液(Ⅱ)
Approval Number
国药准字H20163126
Approval Date
May 8, 2023
NMPA

TABELLAE PARACETAMOLI COMPOSITAE

Product Name
复方对乙酰氨基酚片
Approval Number
国药准字H41023249
Approval Date
Apr 11, 2023
NMPA

Diazepam Tablets

Product Name
地西泮片
Approval Number
国药准字H41023114
Approval Date
Apr 11, 2023
NMPA

Tramadol Hydrochloride and Sodium Chloride Injection

Product Name
西利西蒙
Approval Number
国药准字H20040765
Approval Date
Mar 15, 2023
NMPA

Glibenclamide Tablets

Product Name
格列本脲片
Approval Number
国药准字H41022447
Approval Date
Mar 15, 2023
NMPA

Vitamin U, Aluminium Hydroxide II and Magnesium Trisilicate Tablets II

Product Name
维U颠茄铝镁片Ⅱ
Approval Number
国药准字H41024954
Approval Date
Mar 15, 2023
NMPA

Puerarin Injection

Product Name
葛根素注射液
Approval Number
国药准字H20054812
Approval Date
Mar 15, 2023
NMPA

Ephedrine Hydrochloride and Diphenhydramine Hydrochloride Tablets

Product Name
麻黄碱苯海拉明片
Approval Number
国药准字H41025501
Approval Date
Mar 15, 2023
NMPA

Alprazolam Tablets

Product Name
阿普唑仑片
Approval Number
国药准字H41022444
Approval Date
Mar 15, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.